Midodrine Hydrochloride Tablets Recall 8,892 Cartons Nationwide (2026)
Midodrine Hydrochloride Tablets, 5 mg, 50 tablets in 5 x 10 blister packs, distributed nationwide by Major Pharmaceuticals, are recalled. The packaging defect involves inadequately sealed blister packaging. Healthcare providers and patients should stop using the product immediately and contact The Harvard Drug Group LLC for guidance.
Product Details
Product: Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs)\nNDC: 0904-6818-06\nLot: N02640\nExp: 08/2027\nRecall quantity: 8,892 cartons\nSold/distributed: Nationwide US\nDistributor/packager: Major Pharmaceuticals, Indianapolis, IN 46268 USA\nRecall date: 2026-02-17\nStatus: ACTIVE\nClassification: Class II
The Hazard
Defective container with inadequately sealed blister packaging. The issue may compromise packaging integrity and drug quality. Consumers should not use affected product until guidance is provided.
What to Do
1. Stop using the product immediately. 2. Contact The Harvard Drug Group LLC or your healthcare provider for guidance. 3. Do not dispose of the packaging until instructed by a health professional or the recall notice.
Contact Information
For more information, refer to the FDA recall page listed in the notice. Contact details for the Harvard Drug Group LLC are provided in the recall notification.